TransMedics Group Inc vs T Rowe Price Group Inc — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while T Rowe Price Group Inc trades at $115.59 (market cap $25.14B). The key difference: T Rowe Price Group Inc is far larger — about 9.9× TransMedics Group Inc's market cap, and T Rowe Price Group Inc pays a 4.43% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| TMDX | TROW | |
|---|---|---|
Market Cap | $2.54B | $25.14B |
Sector | Technology | Financials |
52-Week High | $150.42 | $120.16 |
52-Week Low | $61.99 | $86.19 |
Enterprise Value | $2.94B | $21.85B |
Dividend Yield | — | 4.43% |
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →